Cloning/NN
of/IN
ARE-containing/JJ
genes/NNS
by/IN
AU-motif-directed/JJ
display/NN
./.

A/DT
procedure/NN
suitable/JJ
for/IN
cloning/VBG
labile/JJ
mRNAs/NNS
that/WDT
contain/VBP
AU/NN
motifs/NNS
is/VBZ
presented/VBN
(/(
AU-DD/NN
)/)
./.
=====
These/DT
motifs/NNS
are/VBP
regulatory/JJ
sequences/NNS
within/IN
the/DT
so-called/JJ
AU-rich/JJ
elements/NNS
(/(
AREs/NNS
)/)
often/RB
found/VBN
in/IN
3'/JJ
untranslated/JJ
regions/NNS
of/IN
genes/NNS
such/JJ
as/IN
cytokines/NNS
,/,
proto-oncogenes/NNS
,/,
and/CC
transcription/NN
factors/NNS
./.
=====
AU-DD/NN
is/VBZ
an/DT
AU-motif-directed/JJ
differential/JJ
display/NN
that/WDT
permits/VBZ
the/DT
identification/NN
of/IN
ARE-containing/JJ
genes/NNS
differentially/RB
expressed/VBN
after/IN
cell/NN
activation/NN
./.
=====
It/PRP
has/VBZ
been/VBN
applied/VBN
to/TO
peripheral/JJ
blood/NN
monocytes/NNS
and/CC
a/DT
T/NN
cell/NN
clone/NN
to/TO
isolate/VB
59/CD
cDNA/NN
fragments/NNS
associated/VBN
to/TO
activation/NN
./.
=====
Fourteen/CD
percent/NN
of/IN
isolated/VBN
fragments/NNS
belong/VBP
to/TO
already/RB
known/JJ
genes/NNS
that/WDT
certainly/RB
are/VBP
cytokines/NNS
and/CC
transduction/transcription/NN
factors/NNS
./.
=====
The/DT
remaining/VBG
86/CD
%/NN
correspond/VBP
to/TO
unknown/JJ
genes/NNS
of/IN
which/WDT
92/CD
%/NN
have/VBP
been/VBN
confirmed/VBN
to/TO
be/VB
differentially/RB
expressed/VBN
./.
=====
These/DT
data/NNS
demonstrate/VBP
the/DT
efficiency/NN
of/IN
the/DT
system/NN
and/CC
support/VBP
the/DT
notion/NN
that/IN
numerous/JJ
genes/NNS
falling/VBG
into/IN
those/DT
categories/NNS
remain/VBP
unidentified/JJ
and/CC
that/IN
they/PRP
can/MD
be/VB
cloned/VBN
by/IN
this/DT
method/NN
./.
=====
Copyright/NN
1998/CD
Academic/NNP
Press/NNP
./.